Trial Information

Summary: This is a 6-month study to evaluate the incidence of gastric ulcers in subjects at high risk for developing NSAID-associated ulcers.

After meeting all entrance criteria, including an endoscopy to check for the presence of ulcers, subjects will be assigned to take either PN 400 twice a day or naproxen 500mg twice a day for 6 months. Subjects will return at 1, 3 and 6 months for safety assessments, more study drug and an endoscopy. Subjects will also be asked about dyspepsia and related GI symptoms. If either a gastric or duodenal ulcer is detected, study drug will be discontinued and subjects placed on appropriate medication for treatment.

Inclusion and Exclusion Criteria:
Male or non-pregnant female subjects, 18 years and older with a history of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis or other medical conditions expected to require daily NSAID therapy for at least 6 months, with a documented history of an ulcer related serious upper gastrointestinal event such as bleeding, perforation or obstruction.

Female subjects of childbearing potential are required to use acceptable methods of birth control.

Subjects must not have any uncontrolled acute or chronic medical illness, (e.g.; diabetes, hypertension, thyroid disorder, blood disorders, psychiatric disorders and/or infection) or have any drug dependence or overuse of narcotics for management of pain.

Subjects must not have any gastrointestinal disorder or surgery leading to impaired drug absorption or have any gastric or duodenal ulcers at the screening endoscopy. Certain concomitant medications cannot be taken while in the study.

www.PainResearchStudies.com

Contact:

Research Center
Located in:
Daytona Beach, FL
Telephone: 1-888-742-7876

 

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:33:20 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA